1,2-Methylenedioxy-8-(1-adamantanecarbonylamino)-9-methoxycycloberberine chloride

ID: ALA4175675

Chembl Id: CHEMBL4175675

PubChem CID: 145971922

Max Phase: Preclinical

Molecular Formula: C32H31ClN2O4

Molecular Weight: 507.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c[n+]3c4c2ccc2c5c(cc(c24)CC3)OCO5)c1NC(=O)C12CC3CC(CC(C3)C1)C2.[Cl-]

Standard InChI:  InChI=1S/C32H30N2O4.ClH/c1-36-25-5-4-21-22-2-3-23-27-20(11-26-30(23)38-16-37-26)6-7-34(29(22)27)15-24(21)28(25)33-31(35)32-12-17-8-18(13-32)10-19(9-17)14-32;/h2-5,11,15,17-19H,6-10,12-14,16H2,1H3;1H

Standard InChI Key:  ROMDCMGVJZCHMO-UHFFFAOYSA-N

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus saprophyticus (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus hominis (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 507.61Molecular Weight (Monoisotopic): 507.2278AlogP: 5.88#Rotatable Bonds: 3
Polar Surface Area: 60.67Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.38CX Basic pKa: CX LogP: 1.16CX LogD: 1.16
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: 0.51

References

1. Fan T, Hu X, Tang S, Liu X, Wang Y, Deng H, You X, Jiang J, Li Y, Song D..  (2018)  Discovery and Development of 8-Substituted Cycloberberine Derivatives as Novel Antibacterial Agents against MRSA.,  (5): [PMID:29795764] [10.1021/acsmedchemlett.8b00094]

Source